Roelof J.C. Kluin
The Netherlands Cancer Institute(NL)Cancer Genomics Centre(NL)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Histone Deacetylase Inhibitors Research, Click Chemistry and Applications, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics
Most-Cited Works
- → Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial(2019)863 cited
- → Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers(2018)564 cited
- → An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer(2012)219 cited
- → High-throughput identification of antigen-specific TCRs by TCR gene capture(2013)176 cited
- → Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer(2016)174 cited
- → XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data(2018)169 cited
- → Identification of recurrent FGFR3 fusion genes in lung cancer through kinome‐centred RNA sequencing(2013)118 cited
- → Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence(2022)84 cited
- → BRAFV600E Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts(2016)83 cited
- → BRCA1‐like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential(2015)72 cited